These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 13433378)

  • 1. Hyperhydration: a method of decreasing the nephrotoxic effects of Urokon as employed in aortography.
    MORRIS GC; CRAWFORD ES; BEALL AC; MOYER JH
    Surg Forum; 1957; 7():319-22. PubMed ID: 13433378
    [No Abstract]   [Full Text] [Related]  

  • 2. Complication of aortography; factors influencing renal function following aoriography with 70 per cent urokon.
    BEALL AC; CRAWFORD ES; COUVES CM; DEBAKEY ME; MOYER JH
    Surgery; 1958 Mar; 43(3):364-80. PubMed ID: 13647159
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative suitability of urokon 70 per cent and hypaque 90 per cent for use as aortographic contrast media.
    KILLEN DA; LANCE EM; OWENS G
    Surgery; 1959 Mar; 45(3):436-44. PubMed ID: 13635221
    [No Abstract]   [Full Text] [Related]  

  • 4. A plea for caution in the use of sodium acetrizoate (urokon) for aortography.
    LANCE EM; KILLEN DA; SCOTT HW
    Ann Surg; 1959 Jul; 150(1):172. PubMed ID: 13661846
    [No Abstract]   [Full Text] [Related]  

  • 5. Iodinated contrast media and the kidney.
    Weisbord SD
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydration and N-acetylcysteine in acute renal failure caused by iodinated contrast medium: an experiment with rats.
    Pinto CF; Watanabe M; Vattimo Mde F
    J Nephrol; 2008; 21(5):783-8. PubMed ID: 18949735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose protection of the canine kidney against urokon injury during abdominal aortography.
    LANCE EM; KILLEN DA
    Surg Forum; 1960; 11():139-40. PubMed ID: 13758616
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation of means to prevent spinal cord and renal damage incident to Urokon aortography.
    KILLEN DA; LANCE EM
    Surgery; 1962 Mar; 51():338-46. PubMed ID: 14455924
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrotoxicity and the role of contrast media.
    Aspelin P
    Radiat Med; 2004; 22(6):377-8. PubMed ID: 15648451
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain damage following Urokon injection in the brachial artery: report of a case.
    BATSAKIS JG
    Med Bull (Ann Arbor); 1957 Feb; 23(2):45-52. PubMed ID: 13422756
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nephrotoxic action of contrast media].
    Kleinrok A; Kudyk T
    Przegl Lek; 2005; 62 Suppl 2():57-60. PubMed ID: 16623122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kidney injuries and kidney failure caused by drugs].
    Hartmann A; Midtvedt K; Witczak B
    Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2765-6. PubMed ID: 15534671
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of zinc in nephrotoxicity of contrast media used in imaging diagnostics of the cardiovascular system.
    Tubek S; Tubek I
    Biol Trace Elem Res; 2007; 117(1-3):1-5. PubMed ID: 17873387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic reactions incident to urokon aortography as related to the volume of contrast medium injected.
    KILLEN DA; FOSTER JH; SCOTT HW
    Ann Surg; 1962 Mar; 155(3):472-6. PubMed ID: 14455922
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast-induced nephropathy.
    Kabalan SN; El-Imad BG; Geara AS
    J Med Liban; 2007; 55(1):29-38. PubMed ID: 17489305
    [No Abstract]   [Full Text] [Related]  

  • 16. [Which benefit for patient can we expect from hyperhydration and haemodynamic per and postoperative optimization? (I)].
    Carlier M
    Ann Fr Anesth Reanim; 2005 Feb; 24(2):194-8. PubMed ID: 15737506
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complications of translumbar aortography].
    Kovalenko VI; Nikonov VV; Chiniakin IA
    Khirurgiia (Mosk); 1982 Jul; (7):87-90. PubMed ID: 7120842
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?
    Thomsen HS; Morcos SK; Dawson P
    Clin Radiol; 2006 Nov; 61(11):905-6. PubMed ID: 17018301
    [No Abstract]   [Full Text] [Related]  

  • 19. [Secondary nephropathies in occupational health practice. II. Kidney disorders induced by drug and contrast media].
    Antonowicz-Juchniewicz J; Jodkowska A; Kwiecińska D
    Med Pr; 2006; 57(5):455-68. PubMed ID: 17340988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
    Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
    Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.